Literature DB >> 2890904

Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum.

A M Oduola1, W K Milhous, L A Salako, O Walker, R E Desjardins.   

Abstract

West African isolates of Plasmodium falciparum were more susceptible to chloroquine but less susceptible to mefloquine than were Southeast Asian isolates. The West African isolates were more sensitive to halofantrine than to mefloquine. Since neither mefloquine nor halofantrine has been used in West Africa, the findings suggest that P falciparum may be inherently resistant to mefloquine and that mefloquine should be introduced cautiously to West Africa. Moreover, halofantrine may be of greater value than mefloquine for controlling multidrug-resistant falciparum malaria in West Africa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890904     DOI: 10.1016/s0140-6736(87)91195-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

1.  pfmdr1 amplification associated with clinical resistance to mefloquine in West Africa: implications for efficacy of artemisinin combination therapies.

Authors:  Benoit Witkowski; Xavier Iriart; Patrice Njomnang Soh; Sandie Menard; Muriel Alvarez; Veronique Naneix-Laroche; Bruno Marchou; Jean-François Magnaval; Françoise Benoit-Vical; Antoine Berry
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

2.  Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.

Authors:  Benoit Witkowski; Marie-Laure Nicolau; Patrice Njomnang Soh; Xavier Iriart; Sandie Menard; Muriel Alvarez; Bruno Marchou; Jean-François Magnaval; Françoise Benoit-Vical; Antoine Berry
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

Review 3.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

4.  Optimization of endochin-like quinolones for antimalarial activity.

Authors:  Rolf Winter; Jane X Kelly; Martin J Smilkstein; David Hinrichs; Dennis R Koop; Michael K Riscoe
Journal:  Exp Parasitol       Date:  2010-10-30       Impact factor: 2.011

5.  Clearing the air on malaria.

Authors:  R Wittes
Journal:  CMAJ       Date:  1991-03-15       Impact factor: 8.262

6.  Antimalarial activities of new pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives.

Authors:  Jian Guan; Quan Zhang; Michael O'Neil; Nicanor Obaldia; Arba Ager; Lucia Gerena; Ai J Lin
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

7.  An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia.

Authors:  Timothy J Whitman; Philip E Coyne; Alan J Magill; David L Blazes; Michael D Green; Wilbur K Milhous; Timothy H Burgess; Daniel Freilich; Sybil A Tasker; Ramzy G Azar; Timothy P Endy; Christopher D Clagett; Gregory A Deye; G Dennis Shanks; Gregory J Martin
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 8.  Halofantrine: a new substance for treatment of multidrug-resistant malaria.

Authors:  H D Nothdurft; R Clemens; H L Bock; T Löscher
Journal:  Clin Investig       Date:  1993-01

Review 9.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

10.  Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.

Authors:  David J Bacon; Doug Tang; Carola Salas; Norma Roncal; Carmen Lucas; Lucia Gerena; Lorena Tapia; A Alejandro Llanos-Cuentas; Coralith Garcia; Lelv Solari; Dennis Kyle; Alan J Magill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.